• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
Pharmacy Times – Pharmacy Practice News and Expert Insights
Pharmacy Times – Pharmacy Practice News and Expert Insights
Spotlight
Practice PearlsWomen's HealthZoster
Clinical Role
View MoreHospitalOncologyPharmacy TechnicianRetailSpecialty PharmacyStudent
Clinical
View More503B Compounding PharmacyBrain HealthCardiovascular HealthCoronavirusDermatologyDiabetesFluHeart FailureHepatitisImmunizationLymphomaMigrainePneumococcalVitamins and Supplements
News
All News
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Events
Upcoming Events
Upcoming Webinars
CME/CE
Resources
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
eNewsletter
Print Subscription
  • About Us
  • Advertise
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Do Not Sell My Information

© 2022 MJH Life Sciences and Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.

Spotlight
  • Practice Pearls
  • Women's Health
  • Zoster
Clinical RoleSee All >
  • Hospital
  • Oncology
  • Pharmacy Technician
  • Retail
  • Specialty Pharmacy
  • Student
ClinicalSee All >
  • 503B Compounding Pharmacy
  • Brain Health
  • Cardiovascular Health
  • Coronavirus
  • Dermatology
  • Diabetes
  • Flu
  • Heart Failure
  • Hepatitis
  • Immunization
  • Lymphoma
  • Migraine
  • Pneumococcal
  • Vitamins and Supplements
  • About Us
  • Advertise
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Do Not Sell My Information
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.

The Evolving Role of BTK Inhibitors in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

Medical experts detail the current and evolving roles of BTK inhibitors in treatment of patients with relapsed/refractory mantle cell lymphoma.

EP. 1: Defining Oncologic Traits Unique To Mantle Cell Lymphoma

June 21st 2022

Dr Haumschild, PharmD, MS, MBA leads a panel of experts identifying characteristics unique to MCL and addressing initial treatment strategies.

EP. 2: Exploring The Changing Landscape in MCL Treatment

June 21st 2022

Drs Preetesh Jain and Michael Wang exchange insights regarding the current and prospective treatment options for patients with Mantle Cell Lymphoma.

EP. 3: Addressing Unmet Needs in The Relapse/Refractory Setting

June 28th 2022

Preetesh Jain, MBBS, MD, DM, PhD, offers perspective on unmet needs in treatment of patients with relapsed/refractory mantle cell lymphoma.

EP. 4: Key Comorbidity Considerations for Patients With MCL

June 28th 2022

Ryan Haumschild, PharmD, MS, MBA, leads a discussion regarding the treatment of relapsed/refractory mantle cell lymphoma in the presence of comorbidities.